Wave Life Sciences Ltd. (WVE) Financial Statements (2024 and earlier)

Company Profile

Business Address 7 STRAITS VIEW
SINGAPORE, 018936
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments88,497150,564184,497147,161174,819142,503
Cash and cash equivalents88,497150,564184,497147,161174,819142,503
Receivables  30,00020,00010,000 
Prepaid expense7,9326,58410,4349,626  
Other current assets2,1085,4165,1118,689  
Other undisclosed current assets     17,4547,985
Total current assets:98,537162,564230,042185,476202,273150,488
Noncurrent Assets
Operating lease, right-of-use asset26,84318,37816,23218,101
Property, plant and equipment17,28422,26629,19836,36839,93127,334
Long-term investments and receivables    30,00050,000 
Accounts and financing receivable, after allowance for credit loss    30,00050,000 
Restricted cash and investments3,6603,6513,6513,6473,6253,610
Other undisclosed noncurrent assets6214811510,658111411
Total noncurrent assets:47,84944,44349,19698,77493,66731,355
TOTAL ASSETS:146,386207,007279,238284,250295,940181,843
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities20,43121,03324,94122,76526,09816,651
Employee-related liabilities10,1819,0038,6627,5075,428
Accounts payable16,9157,28113,7959,07313,0897,598
Accrued liabilities3,5163,5712,1435,0305,5023,625
Deferred revenue31,55837,09891,56089,652
Debt    3,243 16
Deferred rent credit     115
Deferred revenue and credits2,765
Contract with customer, liability100,945
Other liabilities      156
Other undisclosed current liabilities19,5326,0704,5392,4932,88333
Total current liabilities:71,52164,201121,040118,153130,04119,621
Noncurrent Liabilities
Long-term debt and lease obligation:  24,95525,59129,304  
Liabilities, other than long-term debt112,08277,47941,95565,18775,43011,440
Deferred revenue and credits9,821
Deferred revenue79,77477,47941,48163,466
Contract with customer, liability68,156
Deferred rent credit     5,132
Other liabilities 190 4741,7212,1421,619
Operating lease, liability32,11824,95525,59129,304
Other undisclosed noncurrent liabilities     9,2473,094
Total noncurrent liabilities:112,082102,43467,54694,49184,67714,534
Total liabilities:183,603166,635188,586212,644214,71834,155
Temporary equity, carrying amount7,8747,8747,8747,8747,8747,874
Equity
Equity, attributable to parent(45,091)32,49882,77863,73273,348139,814
Common stock802,833749,851694,085539,547375,148310,038
Additional paid in capital119,44287,98071,57357,27737,76822,172
Accumulated other comprehensive income (loss)(29)181389267153116
Accumulated deficit(967,337)(805,514)(683,269)(533,359)(339,721)(192,512)
Total equity:(45,091)32,49882,77863,73273,348139,814
TOTAL LIABILITIES AND EQUITY:146,386207,007279,238284,250295,940181,843

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues3,64940,96420,07715,98314,4143,704
Gross profit:3,64940,96420,07715,98314,4143,704
Operating expenses(166,369)(167,980)(173,454)(224,300)(173,937)(106,284)
Operating loss:(162,720)(127,016)(153,377)(208,317)(159,523)(102,580)
Nonoperating income1,5784,5672,62614,67912,9391,253
Investment income, nonoperating1,571305844,9123,3681,578
Other nonoperating income (expense)74,5372,0589,7389,549(331)
Loss from continuing operations before income taxes:(161,142)(122,449)(150,751)(193,638)(146,584)(101,327)
Income tax expense (benefit)(681)204841 (69)(708)
Other undisclosed loss from continuing operations      
Loss from continuing operations:(161,823)(122,245)(149,910)(193,638)(146,653)(102,035)
Loss before gain (loss) on sale of properties:(122,245)(149,910)(193,638)(146,653)(102,035)
Net loss available to common stockholders, diluted:(161,823)(122,245)(149,910)(193,638)(146,653)(102,035)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(161,823)(122,245)(149,910)(193,638)(146,653)(102,035)
Other comprehensive income (loss)(210)(208)12211437407
Other undisclosed comprehensive loss      
Comprehensive loss:(162,033)(122,453)(149,788)(193,524)(146,616)(101,628)
Other undisclosed comprehensive income, net of tax, attributable to parent      
Comprehensive loss, net of tax, attributable to parent:(162,033)(122,453)(149,788)(193,524)(146,616)(101,628)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: